HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4+ cell counts

AIDS

Volumn 27, Issue 15, 2013, Pages 2441-2450

  Raugi, Dana N ^a,b   Gottlieb, Geoffrey S ^b   Sow, Papa S ^c   Toure, Macoumba ^c   Sall, Fatima ^c   Gaye, Awa ^d   N'Doye, Ibra ^e   Kiviat, Nancy B ^b   Hawes, Stephen E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d Centre Hospitalier Universitaire Dakar   (Senegal)

^e Institut dHygiene Sociale Dakar   (Senegal)

Author keywords

HIV dual infection; HIV viral load; HIV 1; HIV 2; Senegal

Indexed keywords

CELL DNA; VIRUS DNA; VIRUS RNA;

ADULT; AFRICA; AGE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTITUTION; SEMEN ANALYSIS; SEX; UTERINE CERVIX CYTOLOGY; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; RETROSPECTIVE STUDIES; RNA, VIRAL; SEMEN; SENEGAL; VAGINA; VIRAL LOAD; YOUNG ADULT;

EID: 84884502445     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328362e856     Document Type: Conference Paper

References (40)

1. Arien KK, Abraha A, Quinones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol 2005; 79:8979-8990.
2. De Cock KM, Adjorlolo G, Ekpini E, Sibailly T, Kouadio J, Maran M, et al. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 1993; 270:2083-2086.
3. Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Bartczak S, Pepin JM, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993; 7:1411-1417.
4. Berry N, Ariyoshi K, Jobe O, Ngum PT, Corrah T, Wilkins A, et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994; 10:1031-1037.
5. Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Redman M, Coll-Seck AM, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002; 185:905-914.
6. Matheron S, Courpotin C, Simon F, Di Maria H, Balloul H, Bartzack S, et al. Vertical transmission of HIV-2. Lancet 1990; 335:1103-1104.
7. Kanki PJ, Travers KU, Marlink RG, Essex ME, MBoup S, Gueye-Ndiaye A, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943-946.
8. Whittle H, Morris J, Todd J, Corrah T, Sabally S, Bangali J, et al. HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 1994; 8:1617-1620.
9. Jaffar S, Wilkins A, Ngom PT, Sabally S, Corrah T, Bangali JE, et al. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:327-332.
10. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-1590.
11. Matheron S, Pueyo S, Damond F, Simon F, Lepretre A, Campa P, et al. Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS 2003; 17:2593-2601.
12. Evans LA, Moreau J, Odehouri K, Seto D, Thomson-Honnebier G, Legg H, et al. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet 1988; 2:1389-1391.
13. Leonard G, Chaput A, Courgnaud V, Sangare A, Denis F, Brechot C. Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. AIDS 1993; 7:1185-1189.
14. Walther-Jallow L, Andersson S, da Silva Z, Biberfeld G. High concordance between polymerase chain reaction and antibody testing of specimens from individuals dually infected with HIV types 1 and 2 in Guinea-Bissau, West Africa. AIDS Res Hum Retroviruses 1999; 15:957-962.
15. Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankale JL, Marlink RG, et al. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS 1998; 12:131-137.
16. Travers K, Mboup S, Marlink R, Gueye-Nidaye A, Siby T, Thior I, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995; 268:1612-1615.
17. Rappaport J, Arya SK, Richardson MW, Baier-Bitterlich G, Klotman PE. Inhibition of HIV-1 expression by HIV-2. J Mol Med (Berl) 1995; 73:583-589.
18. Dern K, Rubsamen-Waigmann H, Unger RE. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2. AIDS Res Hum Retroviruses 2001; 17:295-309.
19. Browning CM, Cagnon L, Good PD, Rossi J, Engelke DR, Markovitz DM. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. J Virol 1999; 73:5191-5195.
20. Greenberg AE. Possible protective effect of HIV-2 against incident HIV-1 infection: review of available epidemiological and in vitro data. AIDS 2001; 15:2319-2321.
21. van Tienen C, Schim van der Loeff M, Peterson I, Cotten M, Andersson S, Holmgren B, et al. HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community. PLoS One 2011; 6:e29026.
22. Esbjornsson J, Mansson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med 2012; 367:224-232.
23. Sarr AD, Popper S, Thior I, Hamel DJ, Sankale JL, Siby T, et al. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. J Hum Virol 1999; 2:45-51.
24. Nkengasong JN, Kestens L, Ghys PD, Koblavi-Deme S, Otten RA, Bile C, et al. Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 2000; 16:1371-1378.
25. Koblavi-Deme S, Kestens L, Hanson D, Otten RA, Borget MY, Bile C, et al. Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Cote D'Ivoire. AIDS 2004; 18:413-419.
26. Alabi AS, Jaffar S, Ariyoshi K, Blanchard T, Schim van der Loeff M, Awasana AA, et al. Plasma viral load, CD4+ cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 2003; 17:1513-1520.
27. Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000; 160:3286-3293.
28. Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V, Coulibaly IM, Yeboue KM, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997; 11:F85-F93.
29. Gottlieb GS, Hawes SE, Agne HD, Stern JE, Critchlow CW, Kiviat NB, et al. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS 2006; 20:895-900.
30. Hawes SE, Sow PS, Stern JE, Critchlow CW, Gottlieb GS, Kiviat NB. Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding. AIDS 2008; 22:2517-2525.
31. Pavlinac PB, Hawes SE, Gottlieb GS, Gaye A, N'Diaye CF, Critchlow CW, et al. HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors. Sex Transm Infect 2012; 88:45-50.
32. Drylewicz J, Eholie S, Maiga M, Zannou DM, Sow PS, Ekouevi DK, et al. First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration. AIDS 2010; 24:1043-1050.
33. Adje-Toure CA, Cheingsong R, Garcia-Lerma JG, Eholie S, Borget MY, Bouchez JM, et al. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Cote d'Ivoire. AIDS 2003; 17 (Suppl 3):S49-S54.
34. Zheng NN, McElrath MJ, Sow PS, Hawes SE, Diallo-Agne H, Stern JE, et al. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection. J Virol 2007; 81:9061-9071.
35. Heitzinger K, Sow PS, Dia Badiane NM, Gottlieb GS, N'Doye I, Toure M, et al. Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009. Int J STD AIDS 2012; 23:710-716.
36. Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Coll-Seck AM, Curlin ME, et al. Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa. AIDS Res Hum Retroviruses 2003; 19:575-584.
37. Rouet F, Ekouevi DK, Inwoley A, Chaix ML, Burgard M, Bequet L, et al. Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J Clin Microbiol 2004; 42:4147-4153.
38. Peeters M, Gershy-Damet GM, Fransen K, Koffi K, Coulibaly M, Delaporte E, et al. Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Cote d'Ivoire. Lancet 1992; 340:339-340.
39. World Health Organization. WHO recommendations on the diagnosis of HIV infection in infants and children.Geneva: World Health Organization; 2010. pp. 64.
40. HIV-2 Infection Surveillance - United States 1987-2009. MMWR Morb Mortal Wkly Rep 2011; 60:985-988.